Professional Documents
Culture Documents
Materi Presentasi 1-s2.0-S181808761300007X-main
Materi Presentasi 1-s2.0-S181808761300007X-main
Materi Presentasi 1-s2.0-S181808761300007X-main
ScienceDirect
Article history: In the present study, gel formulations of organogels, hydrogels, and oleo-hydrogel (bigels)
Received 16 January 2013 were evaluated as transdermal drug delivery systems for diltiazem HCL (DH). Organogels were
Received in revised form prepared using soya-bean oil (SO) as a solvent and span 60 (Sp 60), cetyl alcohol (CA) or lecithin-
10 February 2013 pluronic (PLO) as organogelators without and with different surfactants (2% w/w) namely span
Accepted 15 February 2013 80 (Sp80), tween 20 (T20) and tween 80 (T80). On the other hand, hydrogels were formulated
using Hydroxypropyl-methylcellulose (HPMC) polymer and bigels were prepared by mixing
Keywords: organogels with HPMC hydrogels. The prepared gels were analyzed microscopically, ther-
Organogels mally by DTA and for pH, and viscosity. The effect of gelator used, surfactant types and pH of
Hydrogels the sink on DH release from cellophane membrane was investigated. In addition, the DH
Bigels permeability across the rabbit skin was evaluated. Finally, the in vivo performance of various
Lecithin gel formulations was assessed based on the hypotensive effects of the drug using hypertensive
Span albino male rat models. The microscopical analysis indicated that the solid fibers formed by
gelator particles form the backbone of the organogels while bigels appeared as emulsion like.
The addition of surfactants showed an increase in organogel viscosity. The thermal analysis of
organogels indicated that the drug present in amorphous not in crystalline form. The release
studies indicated that DH release from organogels, hydrogels and bigels could be controlled.
The included surfactants decreased the DH release and permeation from organogels
compared to those without surfactants using either Sp60 or CA. HPMC hydrogel and Bigels
showed higher DH release and permeation rates when compared to organogels. The percent
DH released in different pH values was in the following descending order:
pH5.5>pH1.2>pH6.8>pH7.4. The in vivo antihypertensive activity of DH using different
transdermal gels is arranged as following: hydrogels > PLO organogel > bigel> Sp 60 organogel.
ª 2013 Shenyang Pharmaceutical University. Production and hosting by Elsevier B.V. All
rights reserved.
* Corresponding author. Department of Pharmaceutics, Faculty of pharmacy, Zagazig University, Zagazig, Egypt. Tel.: þ20 552303266.
E-mail address: mahmoud_dsky@zu.edu.eg (M.M. Ibrahim).
Peer review under responsibility of Shenyang Pharmaceutical University
Sp60/SO organogel 1 e e e e e e e 7 e 2
Sp60/Sp80 orgaanogel 1 e 0.2 e e e e e 6.8 e 2
Sp60/T20 organogel 1 e e 0.2 e e e e 6.8 e 2
Sp60/T80 organogel 1 e e e 0.2 e e e 6.8 e 2
CA/SO organogel e 1 e e e e e e 7 e 2
CA/Sp80 organogel e 1 0.2 e e e e e 6.8 e 2
CA/T20 organogel e 1 e 0.2 e e e e 6.8 e 2
CA/T80 organogel e 1 e e 0.2 e e e 6.8 e 2
PLO e e e e e 1 0.5 e 4 2.5 2
HPMC hydrogel e e e e e e e 1 e 7 2
Sp60/HPMC bigel 0.5 e e e e e e 0.5 2.5 4.5 2
Sp60/Sp80/HPMC bigel 0.5 e 0.1 e e e e 0.5 2.4 4.5 2
Sp60/T20/HPMC bigel 0.5 e e 0.1 e e e 0.5 2.4 4.5 2
Sp60/T80/HPMC bigel 0.5 e e e 0.1 e e 0.5 2.4 4.5 2
CA/HPMC bigel e 0.5 e e e e e 0.5 2.5 4.5 2
CA/Sp80/HPMC bigel e 0.5 0.1 e e e e 0.5 2.4 4.5 2
CA/T80/HPMC bigel e 0.5 e e 0.1 e e 0.5 2.4 4.5 2
for a period of 2 h until complete hydration and gel formation. 2.7. In vitro release study
DH solution (750 mg/ml) was added to the dispersions with
continuous stirring until homogenous gel was formed and the In vitro release of DH from different gel formulations was per-
drug concentration was adjusted to be 150 mg/1 g. formed using shaker water bath (Serve well Instruments and
Equipment, Pvt. Ltd. India) maintained at temperature of
2.2.4. Bigels 32 C 1 C and allowed to agitate at 50 rpm. One gram of the gel
The prepared gels were stored separately at 4 C for at least was weighed in plastic holders then attached to a permeation
24 h, then bigels were prepared by mixing HPMC hydrogels cell previously specified by Mahmoud et al. and covered with
with the Sp60 or CA organogels (1:1 w/w) prepared without or the cellophane membrane (soaked in phosphate buffer pH 5.5
with different surfactants. for 24 h before use) [14]. The cell was immersed to the depth of
1 cm below the surface of the phosphate buffer (pH 5.5) in the
2.3. Microscopic study receptor compartment (50 ml). Samples of 3 ml each from the
receptor compartment was taken at various time intervals of
A compound optical microscope (Olympus B 41) was used for 15, 30, 60, 120, 180, 240, 300 and 360 min and assayed for DH at
analyzing the microstructure of the organogel, hydrogel and 237 nm using UVeVisible Spectrophotometer (Shimadzu-UV-
bigels. Attempts were used to understand the mechanism of 1201, Japan). To maintain sink condition, the sample volume
the gel formation by varying the composition and proportion was replaced with equal volume of the fresh buffer maintained
of the ingredients used and analyzing their microstructure. at 32 C. Each experiment was carried out in triplicate.
of Veterinary medicine, Zagazig University, Egypt. Animals The antihypertensive effects of the selected formulations
were treated according to Ethical committee of animal were studied after induction of hypertension into rats and the
handling in Zagazig University “ECAHZU”. Firstly, hyperten- results were compared to that of the control (group I). For
sion was induced in rats by complete left renal artery ligation in vivo performance, gels which showed the highest release
according to the method described by Cangiano et al. [17]. rates both through the cellophane membrane and the
Postoperatively, the rats were given penicillin G (100,000 units permeability across rabbit skin were selected. The antihy-
I.M.) per rat for three successive days, and were allowed free pertensive activity was studied at different time intervals after
access to food and water for 28 days till the complete induc- application (1, 2, 3, 4, 5 and 6 h) to differentiate between the
tion of hypertension [18]. In vivo studies were done using DH onset of action of the oral DH solution and transdermal gel
formulations of Sp60/SO organogel, HPMC hydrogel, PLO and formulations. The mean arterial blood pressure was calcu-
Sp60/HPMC bigel to evaluate their antihypertensive effects lated according to the following equation [22]:
when administered transdermally. Results were compared
with that of the non treated rats as negative controls and Mean arterial B:P ¼ Diastolic B:P
those administered oral DH solution as positive controls. ðSystolic B:P Diastolic B:PÞ
þ
Animals were divided into six groups as listed in Table 2. Each 3
group consisting of six rats (n ¼ 6) and allowed the application 2.10. Statistical analysis
of 0.2 g of different gel formulations which containing 30 mg of
DH on the hairless skin of the abdomen region (about 4 cm2 in All values were expressed as mean SD. Data were analyzed
size). The negative control group was received placebo statistically using one way analysis of variance (ANOVA) test.
hydrogel free from drug. The positive control group (300 g The level of significance was considered at P < 0.05.
weighed rats) received the dose of 0.027 ml of oral DH solution
which containing 2.025 mg of DH.
The oral dose calculated according to Paget’s equation [19]:
3. Results and discussion
The therapeutic dose for rat weighing 200 g
18 Adult human therapeutic dose ð75 mgÞ Different organogelators were dissolved in the hot oil phase
¼ ¼ 1:35 mg until a clear homogenous solution was obtained. As the tem-
1000
perature cooled down, the gelators precipitated in the oil due to
On the other hand, according to Fick’s first low, the drug
changes in the solubility parameters. The precipitated gelators
efflux increased across the skin as the concentration gradient
grown in size as fibers or reverse cylindrical micelles. The fibers
increased [20]. To reach the maximum thermodynamic ac-
or the micelles physically entangled with each other to form a
tivity, the drug concentration in the donor compartment
three dimensional networked structure [23]. The gel containers
applied transdermally must be maximum or in the saturation
were then inverted and observed for any flow (Fig. 1). Samples
state. Accordingly, DH concentration in the transdermal gels
were considered as organogels if they did not flow [12]. All the
to be tested was kept as high as possible (30 mg/0.2 g gel).
prepared gels except those of the PLO were white to pale yellow
The blood pressure measurements were done using
in color, oily in touch, opaque in nature and no odor.
Oscillograph (Washington, 400 MD 4C, Bio Science, Sheerness,
Concerning PLO, it was jelly like in appearance with yellow
Kent, U.K) at time intervals from 0 to 6 h. The rats were
color, and aqueous touch. On the other hand, the prepared DH
anaesthetized with urethane (ethyl carbamate) in a dose of
hydrogel was transparent, homogenous, clear and smooth
1.75e2.0 g/kg body weight then injected I.P as 25% freshly
with aqueous touch because the liquid compartment is water.
prepared aqueous solution. Intra arterial cannulation was
In addition, bigels (combined forms of hydrogels with orga-
done and the systemic arterial blood pressure was recorded
nogels) were white in color, creamy in appearance with ho-
and the blood pressure of rats was determined employing the
mogenous smooth non oily touch. It is well known that a large
method of Burden et al. [21].
number of emulsifiers could affect the properties of lamellar
lipids of the intracellular matrix of the SC, resulting in the
increased transepidermal water loss and several irritant re-
Table 2 e Classification of in vivo transdermal and oral actions [24]. However, the simple composition of organogels,
groups. bigels and hydrogels is therefore beneficial considering the
Groups Formulation safety of these formulations.
Group (I) Control and received placebo gels
free from drug (ve control). 3.1. Gel morphology
Group (II) Received 0.2 g of Sp60/SO organogel
which containing 30 mg of DH.
roup (III) Received 0.2 g PLO about which
The variations in the microstructure of organogels were
containing 30 mg of DH. studied as the gelator and/or surfactant types changed (Fig. 2).
Group (IV) Received 0.2 g of SP60/HPMC bigel The results showed the presence of needle shaped clusters of
which containing 30 mg of DH. Sp60 when 10% (w/w) gelator concentration was used (Fig. 2).
Group (V) Received 0.2 g of HPMC hydrogel As another surfactant added such as T80, T20, or Sp80, these
which containing 30 mg of DH.
clusters aggregated to form fiber-like structures. These fiber-
Group (VI) Received 0.027 g of oral solution
like structures were in the form of networked skeleton
which containing 2.025 mg of DH (þve control)
which could help in the immobilization of the oil. Hydrogel
52 a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 4 8 e5 7
Fig. 1 e Gelation process of the organogel (a) Clear solution after heating; (b) Uniform, cloudy suspension upon cooling and
standing; (c) Opaque, semi-solid gel upon further standing.
showed Blank pictures where bigels appeared emulsion like DH. This indicated the interaction of the gel clusters of Sp60
with the oil phase dispersed in a continuous aqueous one. and DH which pointed to the presence of the drug in the
amorphous nature (Fig. 3(e)). These results agree with that
3.2. Thermal analysis of Sultana et al., who found that the endothermic peak of
DH in alginate microspheres was not distinctive indicating
The thermogram of DH showed a single sharp endothermic that, the drug was no longer present in the crystalline
peak at 207.55 C and another broad one at 245.50 C form [26].
(Fig. 3(a)). The sharp endothermic peak is corresponding to
the melting point of the drug where the broad one is cor- 3.3. Measurements of the gel pH and viscosity
responding to its decomposition [25]. Also, Fig. 3 (b and c)
showed strong endothermic peaks at 48.78 C and 50.93 C The pH values of the organogels, hydrogels and bigels were
which indicated the melting points of CA and Sp60, found to be in the range of 4.66e5.91 (Table 3), which were
respectively. DTA-thermogram of DH-CA organogel showed close to skin pH 4.5e7 [27]. This enhances a safe application to
a small and broad peak of DH appeared at 208 C (Fig. 3(d)). the skin without irritation problems. All gel formulations were
However, Sp60-DH organogel showed shifting of DH peak found to have viscosities in the range of 870 cP to 34900 cP, and
from 207 C to 188 C and become smaller than that of pure as a general observation, the incorporation of surfactants
Fig. 2 e Microscopic study of different gel formulations, a) Sp60/SO organogel. b) Sp60/Sp80 organogel. c) HPMC hydrogel. d)
microstructure of bigel.
a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 4 8 e5 7 53
70
CA
60 Sp 60
40
30
20
10
0
Fig. 3 e Thermal analysis, a) Pure DH, b) Pure CA, c) Pure 0 50 100 150 200 250 300 350 400
Sp60, d) DH-CA organogel and e) DH-Sp60 organogel. Time (min)
a 70 b 70
HPM C hydrogel HPM C hydrogel
60 Sp60 CA
Sp60/2%Sp80 60
% Diltiazem HCl released
CA/2% sp 80
Sp60/2%T20
30 30
20 20
10 10
0 0
0 50 100 150 200 250 300 350 400 0 50 100 150 200 250 300 350 400
Time (min) Time (min)
c 70 d 80
60 70
% Diltiazem HCl released
60
Fig. 5 e Release profiles of DH from different vehicles. (a) Sp60 organogels vs. HPMC gel, (b) CA organogels vs. HPMC gel, (c)
Bigels of Sp60, and (d) Bigels of CA.
in micelle formation produced an increased area of micellar shown in Fig. 5(d). It is clear that all bigels gave significantly
overlap might be the reason for linear increase in the viscosity higher release rates than organogels (P < 0.05). This may be
of the organogel [34]. attributed to the fact that organogels are W/O type emulsions
The release of DH from HPMC hydrogel was also included having an external lipid phase [11], while a bigel is a w/o/w
in this study and compared with organogels. The percentage type emulsion due to the incorporation of the organogel inside
DH released from HPMC hydrogel was 55.64% after 360 min as the hydrogel which have an external aqueous phase and
shown in Fig. 5 (a and b). The hydrogels are three dimensional capable of incorporating large amounts of water [35]. The
polymeric networks with chemical or physical cross links hydrophilic nature of the external aqueous environment of a
which can control the drug delivery via controlling the base bigel facilitates the release of the hydrophilic drug from the
viscosity [35]. The amount of DH released from hydrogels of external aqueous phase. The release would be faster for a
HPMC was higher than that from all organogels. This may be hydrophilic drug in case of o/w emulsion, since it is in the
due to the aqueous liquid component of hydrogels which can continuum region. The diffusion is difficult when DH incor-
impede large amount of water or biological fluid [35]. On the porated in w/o type emulsion base, since it gets trapped in
other hand, organogels has a liquid organic (lipophilic) me- water droplets. The reverse is true for hydrophobic drugs [36].
dium which make the release of freely water soluble drug To show the effect of the pH of the external sink on DH
more difficult. release, CA/SO organogel and CA/HPMC bigel were formulated
Several formulations of bigels prepared by using different and tested for DH release in different pH values. Fig. 6(a)
organogels of Sp60 or CA with SO with or without different showed that the percentage DH released from CA/SO orga-
surfactants (Sp80, T20 or T80) and mixed with HPMC hydrogel. nogel and CA/HPMC bigel after 360 min was 50.4 and 72.28%
From Fig. 5(c), it was illustrated that the percentage DH when pH was 5.5, 33.80% and 51.48% at pH 1.2, 24.96% and
released after 360 min from different bigels of Sp60/HPMC, 32.68% at pH 6.8, and 14.66% and 18.09% at pH 7.4, respec-
Sp60/Sp80/HPMC, Sp60/T20/HPMC and Sp60/T80/HPMC were tively. The amount of DH released in different pH values was
59.80%, 55.12%, 48.36% and 46.28%, respectively. While, in the following descending order: pH 5.5 > pH 1.2 > pH
72.28%, 54.60% and 41.08% of DH were released from bigels of 6.8 > pH 7.4. Diltiazem is a basic drug and should be more
CA/HPMC, CA/Sp80/HPMC and CA/T80/HPMC, respectively as soluble in the acidic media than neutral and alkaline media.
a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 4 8 e5 7 55
a 100 b
2000
CA/HPMC (pH 5.5)
90 CA organogel (pH 5.5) HPMC hydrogel
CA/HPMC (pH 1.2) 1800
PLO
CA organogel (pH 1.2)
80 CA/HPMC (pH 6.8) 1600 Sp60/HPMC
50 1000
40 800
30 600
20 400
10 200
0 0
0 50 100 150 200 250 300 350 400 0 50 100 150 200 250 300 350 400
Time (min) Time (min)
Fig. 6 e (a) represents the release of DH from CA organogels and bigels in different pH values and (b) represents the
permeation of DH from hydrogel, PLO, bigel and organogel formulations across Rabbit skin.
However, the decline in the DH solubility in HCl buffer pH 1.2 rabbit skin using hydrogels of DH. Concerning PLO organogel,
was attributed to the common ion effect, which provided the amount of DH permeated was higher than Sp60/SO and CA/
unexpected trend in solubility of this medicament in the SO organogels due to the aqueous external compartment and
presence of chloride ion in the medium [37]. On the other the amphiphilic nature of phospholipids which can enhance
hand, high amounts of DH were released in pH 5.5 which in skin penetration and absorption of both lipophilic and hydro-
turn were gradually decreased at pH 6.8 and 7.4. The result philic drugs [40]. The phospholipid tail of micelles could interact
might be due to the acidic nature of DH salt of a basic drug with the lipids in SC causing their rearrangement and thus
having pka of 7.7 and the molecule is freely soluble in water. facilitated drug penetration between epidermal cells into sys-
The high the release profile of DH can be attributed to rapid temic circulation [41]. Also, bigels of Sp60/HPMC and CA/HPMC
ionization and higher solubility of the drug in pH 5.5, however gave higher penetration rates than their organogels and this
the reduced release rate of DH in pH 7.4 could be due to the could be as discussed before due to the external aqueous phase
reduced the extent of ionization and solubility of DH in basic of bigel as well as the surfactant activity of CA and Sp60. CA/SO
media [37]. organogel gave the lowest fluxes which may be ascribed to its
lower surface activity and higher viscosity (3400 cP) when
3.5. In vitro rabbit skin permeation study compared to Sp60/SO organogel (1000 cP).
The aim of this study was to examine the possibility of using 3.6. In vivo study of DH
organogels, hydrogels and bigels as transdermal delivery forms.
Fig. 6(b) shows the cumulative amount of DH expressed in mg/ Fig. 7 shows the significant decrease in the mean arterial blood
cm2 transferred from different gel formulations to the receptor pressure in all hypertensive rats receiving transdermal DH gels
compartment (phosphate buffer pH 5.5). Throughout the compared to the group I (ve control) at all time intervals. The
experiment period, the hydrogel of HPMC showed higher one way ANOVA test revealed that the difference between the
amount of DH skin permeability than other organogel formu- antihypertensive effects of DH in all transdermal groups was
lations. After 360 min, about 1569.50, 1286.28, 1121.07, 1062.0, statistically significant (P < 0.05) when compared to control
979.46 and 483.83 mg/cm2 of DH were permeated across rabbit group at all time intervals of the experiment. Group VI which
skin from HPMC hydrogel, PLO, Sp60/HPMC bigel, CA/HPMC received oral doses of DH solution showed a sharp decrease in
bigel, Sp60/SO and CA/SO organogel formulations, respectively. blood pressure after 1 h (92 mmHg) then gradually increased
Firstly, it must be taken into consideration that the partitioning after the fourth hour. A statistical significant difference
of a drug between the skin and the reservoir favors more lipo- (P < 0.05) was found between oral solution group and all
philic drug because skin act as an organic phase [38]. Skin is a transdermal groups during the first 2 h. Meanwhile, no statis-
horny layer so penetration of drugs is very less. To improve the tical significance (P > 0.05) was observed after 3 h till the end of
penetration of a drug into the skin, chemical enhancers are the experiment between transdermally applied organogels,
added. Incorporation of HPMC enhances the flux of drugs [39]. bigels and oral DH solution. On the other hand, group V which
Hydrogel consists of an aqueous phase which facilitates the received HPMC hydrogel showed a statistical significant dif-
penetration of hydrophilic drug. Also, lower gel viscosity might ference (P < 0.05) compared with oral solution group after 4 h till
be another reason for higher amount of DH permeated the the end of the experiment. This result may be attributed to the
56 a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 4 8 e5 7
180 systems like hydrogels, PLO and bigels may be tried as matrices
which hold good promise for transdermal drug delivery of DH.
160
Mean arterial B.P (mmHg)
140
120 references
100
80
Control [1] Barrat GM. Therapeutic applications of colloidal drug
60 Sp60/SO organogel carriers. Pharm Sci Technol Today 2000;3:163e171.
PLO [2] O’Connor SE, Grosset A, Janiak P. The pharmacological basis
40 Sp60/HPM C bigel and pathophysiological significance of the heart rate
20 HPM C hydrogel lowering property of diltiazem. Fundam Clin Pharmacol
DH oral solution
0 1999;13(2):145e153.
0 2 4 6 [3] Margret C, Chandramohan, Debjit, et al. Design and charac
Time (h) terisation of sustain release gastro retentive floating tablets of
diltiazem hydrochloride. Der Pharmacia Lettre 2009;1(2):25e38.
Fig. 7 e Mean arterial blood pressure of rat groups received [4] Gannu R, Vishnu YV, Kishan V, et al. Development of
different DH gel formulations via the transdermal route nitrendipin transdermal patches. Curr Drug Deliv 2007;4:69e76.
compared with non treated group and those taken DH [5] Rajesh K, Pitchaimani R. Formulation of transdermal drug
delivery system. Curr Drug Discov Technolo 2006;3:279e285.
solution via the oral route. Data represented as mean ± SD
[6] Eaglstein WH. Moist wound healing with occlusive dressings:
(n [ 6). a clinical focus. Dermatol Surg 2001;27:175e181.
[7] Murdan S. Organogels in drug delivery. Expert Opin Drug Del
2005;2:489e505.
fact that the hydrogel gives faster antihypertensive effect when [8] Terech P, Weiss RG. Low molecular mass gelators of organic
liquids and the properties of their gels. Chem Rev
compared with other transdermal groups as it decreased the
1997;97:3133e3160.
blood pressure gradually and maintained it. From these results [9] Shchipunov YA. Lecithin organogel: a micellar system with
all transdermal gels can give comparable results to oral solution unique properties. Colloids Surf A Physicochem Eng Asp
and reveal a sustained antihypertensive effect. A statistical 2001;183-185:541e554.
significant difference (P < 0.05) between group V (hydrogel) and [10] Murdan S. A review of pluronic lecithin organogel as a topical
group II (Sp60 organogel) was observed at all times of the and transdermal drug delivery system. Hosp Pharmacist
2005;12:267e270.
experiment. However, groups III (PLO) and IV (bigel) showed no
[11] Almeida IF, Fernandes AR, Fernandes L, et al. Moisturizing
statistical difference (P > 0.05) at all times of experiment. The
effect of oleogel/hydrogel mixtures. Pharm Dev Technol
results which obtained with all transdermal groups revealed 2008;13:487e494.
that, the antihypertensive effects of DH could be arranged in [12] Shaikh IM, Jadhav SL, Jadhav KR, et al. Aceclofenac
the following order: hydrogel > PLO > bigel > Sp60 organogel. organogels: in vitro and in vivo characterization. Curr Drug
As explained previously, this may be attributed to the external Deliv 2009;6:1e7.
aqueous phase of hydrogels which facilitate DH release from [13] Lognathan V, Manimaran S, Jaswanth A, et al. The effect of
polymers and permeation enhancers on release of flubiprofen
the formula in contrast to organogels which has an external
from gel formulations. Ind J Pharm Sci 2001;63(3):200e204.
lipophilic phase that hinder the DH release. In addition the [14] Mahmoud MI, Omaima AS, Mohamed AH, et al. In vitro
aqueous external phase provides epidermal cell hydration and evaluation of proniosomes as a drug carrier for flurbiprofen.
swelling which enhances hydrophilic drug diffusion across SC. AAPS Pharm Sci Tech 2008;9(3):782e790.
PLO and bigels both contain external aqueous phase facilitating [15] Ghazy FS, Ghareeb SA, Mahdy MA, et al. Comparative in vitro
the release of DH in addition to surface active components and in vivo studies of transdermal absorption of certain
which can enhance skin penetration ability. vasodilators. Alex J Pharm Sci 2004;18(2):151e158.
[16] Mura P, Faucci MT, Bramanti G, et al. Evaluation of transcutol
as a clonazepam transdermal permeation enhancer from
hydrophilic gel formulations. Eur J Pharm Sci 2000;9:365e372.
4. Conclusion [17] Cangiano JL, Rodriguez SC, Martinez MM. J Pharmacol Exp
Ther 1979;208(2):310e313.
The above mentioned results revealed that, the natures of the [18] Douglas JR, Johnson EM, Heist JF, et al. J Pharmacol Exp Ther
1976;196:35e43.
active drug and other ingredients of the gels, as well as the vis-
[19] Paget GE, Barnes JM. Interspecies dosage conversion schem
cosity of the matrix, will affect the drug release profiles from in evaluation of results and quantitative application in
different gels. In vitro release and permeation studies indicated different species. In: Laurence DR, Bacharach AL, editors.
prolonged release of DH from the tested organogels, hydrogels Evaluation of drug activities: pharmacometrics, vol. 1.
and bigels. Hydrogel formulation gave better results among London, New York: Academic Press; 1964. p. 160e162.
other tested formulations. In vivo studies indicated that all [20] Amidon GL, Lennernas H, Shah VP, et al. A theoretical basis
for a biopharmaceutic drug classification: the correlation of
transdermal formulations can give sustained antihypertensive
in vitro drug product dissolution and in vivo bioavailability.
effects. Organogels can effectively enhance the hydrophilic drug
Pharm Res 1995;12:413e420.
delivery across the skin however this investigation revealed that [21] Burden DT, Balber LC, Natoff IL. A simple method for
they could not be suggested as the vehicle of choice for trans- recording left ventricular pressure and heart rate in cats. J
dermal application of hydrophilic drugs. Conversely, watery gel Pharmacol Ther 1979;5:99e102.
a s i a n j o u r n a l o f p h a r m a c e u t i c a l s c i e n c e s 8 ( 2 0 1 3 ) 4 8 e5 7 57
[22] Darne B, Girerd X, Safar M, et al. Pulsatile versus steady of theophylline from HPMC matrices. STP Pharma Sci
component of blood pressure: a cross-sectional analysis and 1999;9:555e560.
a prospective analysis on cardiovascular mortality. [32] Pisal S, Shelke V, Mahadik K, et al. Effect of organogel
Hypertension 1989;13(4):392e400. components on in vitro nasal delivery of propranolol
[23] Trivedi DR, Ballabh A, Dastidar P, et al. Structure property hydrochloride. AAPS PharmSciTech 2004;5(4):92e100.
correlation of a new family of organogelators based on [33] Yaghmur A, Campo L, Aserin A, et al. Structural
organic salts and their selective gelation of oil from oil/water characterization of five component food grade oil in water
mixtures. Chemistry 2004;10:5311e5322. nonionic microemulsions. Phys Chem Chem Phys
[24] Effendy I, Maibach HI. Surfactants and experimental irritant 2004;6(7):1524e1533.
contact dermatitis. Contact Dermatitis 1995;33(4):217e225. [34] Murdan S, Gregoriadis G, Florence AT. Non-ionic surfactant
[25] Mazzo DJ, Obetz CL, Shuster J. In: Britain HG, editor. organogels incorporating niosomes. STP Pharma Sci
Diltiazem hydrochloride. Analytical profiles of drug 1996;6:44e48.
substances and excipients, vol. 23. San Diego: Academic [35] Cociello T, Matricardi P, Marianecci C, et al. Polysaccharide
Press; 1994. p. 54e98. hydrogels for modified release formulations. J Control Rel
[26] Sultana Y, Mall S, Maurya D, et al. Preparation and in vitro 2007;119:5e24.
characterization of diltiazem hydrochloride loaded alginate [36] Gupta S. Bicompatible microemulsion systems for drug
microspheres. Pharm Dev Tech 2009;14(3):321e331. encapsulation and delivery. Curr Sci 2011;101(2):174e188.
[27] Worth AP, Cronin MTD. The use of pH measurements to [37] Phaechamud T. Variables influencing drug release from
predict the potential of chemicals to cause acute dermal and layered matrix system comprising hydroxypropyl
ocular toxicity. Toxicology 2001;169:119e131. methylcellulose. AAPS PharmSciTech 2008;9(2):668e674.
[28] Ruı́z MMA, Gallardo JLV, Benavides MM, et al. Rheological [38] Lehmann KA, Zech D. Transdermal fentanyl clinical
behavior of gels and meloxicam release. Int J Pharm pharmacology. J Pain Symptom Manage 1992;7:S8eS16.
2007;333:17e23. [39] Ghosal K, Chakrabarty S, Nanda A. Hydroxypropyl
[29] Vintiloiu A, Leroux JC. Organogels and their use in drug methylcellulose in drug delivery. Der Pharmacia Sinica
delivery-A review. J Control Rel 2008;125(3):179e192. 2011;2(2):152e168.
[30] Yang Y, Wang S, Xua H, et al. Properties of topically applied [40] Scartazzini R, Luisi PL. Organogels from lecithins. J Phys
organogels: rheology and in vitro drug release. Asian J Pharm Chem 1988;92(3):829e833.
Sci 2008;3(4):175e183. [41] Willimann H, Walde P, Lusi PL, et al. Lecithin organogels as
[31] Nokhodchi A, Khaseh P, Ghafourian T, et al. The role of matrix for transdermal transport of drugs. J Pharm Sci
various surfactants and fillersin controlling the release rate 1992;81:871e874.